RNF144A exerts a negative regulatory effect on the expression of GMFG in breast cancer by specifically targeting YY1-degrading proteasomes, thereby preventing the proliferation, migration, and invasion of breast cancer cells (Zhang et al., 2022). Here, YY1 is linked to breast carcinoma.